AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2015
Jun 11, 2015
31046_dirs_2015-06-10_0423ad56-40e4-4329-867f-3076c8de6aa5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-06-08
Reporting Person: ALDRICH RICHARD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-08 | Common Stock | M | 7000 | $10.85 | Acquired | 7000 | Direct |
| 2015-06-08 | Common Stock | S | 6896 | $55.65 | Disposed | 104 | Direct |
| 2015-06-08 | Common Stock | S | 104 | $56.05 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-08 | Stock Option (Right to Buy) | $10.85 | M | 7000 | Disposed | 2025-06-09 | Common Stock (7000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (10000) | 10000 | Direct |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (12000) | 12000 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person.
F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.05 to $56.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.05 to $56.08 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.